BioWorld Asia

Feb. 22, 2006

EU Research Funding Plan Hits New Biotech Snags

BRUSSELS, Belgium - The European Union could start pumping as much as $3 billion a year in biotechnology and health research beginning next January if its new seven-year support program wins approval. (BioWorld International) Read More

Ark’s Scavidin Increasing Anticancer Drugs’ Efficacy

Bristol Researchers Developing Cancer Therapy Based On IGF2

Bavarian Nordic Opens Austrian Front In Acambis Patent Dispute

Despite Reluctance, France Drafts Bill Covering GMOs

UK Considers Egg Donations For Use In Stem Cell Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 31, 2025.

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...

IMV-101 shows promise for B-cell malignancies

BioWorld Science

IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...